17769171. COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES simplified abstract (The Regents of the University of California)
Contents
- 1 COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES
Organization Name
The Regents of the University of California
Inventor(s)
Hui Sun of Los Angeles CA (US)
Adrian Chichuen Au of Los Angeles CA (US)
Guo Cheng of Los Angeles CA (US)
COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES - A simplified explanation of the abstract
This abstract first appeared for US patent application 17769171 titled 'COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES
Simplified Explanation
The present disclosure is about methods for preparing a tissue sample for detecting the expression of transmembrane proteins PLXDC1 or PLXDC2, as well as providing antibodies and treatments for tumor samples expressing these proteins.
- Detection of transmembrane protein expression in tissue samples
- Targeting tumor samples expressing PLXDC1 or PLXDC2 proteins with antibodies and treatments
Potential Applications
This technology could be used in:
- Cancer research
- Drug development targeting PLXDC1 and PLXDC2 proteins
Problems Solved
This technology helps in:
- Identifying transmembrane protein expression in tissue samples
- Targeting tumor samples expressing specific proteins for treatment
Benefits
The benefits of this technology include:
- Improved detection of transmembrane protein expression
- Targeted treatments for tumors expressing PLXDC1 or PLXDC2 proteins
Potential Commercial Applications
A potential commercial application of this technology could be:
- Developing diagnostic tools for detecting transmembrane protein expression in tumors
Possible Prior Art
One possible prior art could be:
- Methods for detecting protein expression in tissue samples using immunohistochemistry
What are the specific methods for preparing a tissue sample for detection of transmembrane protein expression?
The specific methods for preparing a tissue sample for detection of transmembrane protein expression involve sample collection, processing, and analysis using techniques such as immunohistochemistry.
How do the antibodies and treatments target tumor samples expressing PLXDC1 or PLXDC2 proteins?
The antibodies and treatments target tumor samples expressing PLXDC1 or PLXDC2 proteins by specifically binding to these proteins and inhibiting their function, leading to potential therapeutic effects.
Original Abstract Submitted
The present disclosure relates generally to methods for preparing a tissue sample for detection of the expression of a transmembrane protein in the tissue sample. The present disclosure also provides antibodies and treatments targeting tumor samples expressing the PLXDC1 or the PLXDC2 proteins.